RXDX

Prometheus Biosciences, Inc. Common Stock

Delisted

RXDX was delisted on the 15th of June, 2023.

144 hedge funds and large institutions have $1.94B invested in Prometheus Biosciences, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 51 increasing their positions, 30 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
144
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$38.7M
Puts
$41.4M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
76
$1.19M
77
$1.18M
78
$1.13M
79
$1.1M
80
$1.03M
81
$976K
82
$955K
83
$950K
84
$911K
85
$858K
86
$832K
87
$816K
88
$815K
89
$769K
90
$681K
91
$679K
92
$658K
93
$555K
94
$535K
95
$526K
96
$514K
97
$511K
98
$507K
99
$506K
100
$493K